Background: Confocal microscopy is a second-level examination for dermoscopically equivocal melanocytic lesions. However, the number of false-negative cases on confocal microscopy and the scenarios in which confocal microscopy may fail have not been fully elucidated. Objective: To calculate the percentage of false-negative melanomas upon reflectance confocal microscopy examination in a large series of cases. Methods: A retrospective analysis on 201 melanomas, evaluated for dermoscopic/confocal criteria of melanoma, was carried out. Results: Twenty-three melanomas out of 201 cases (11.4%) revealed a low 7-point checklist score. On confocal examination, 22 out of 23 lesions have been diagnosed correctly as melanomas. Only 1 lesion did not display melanoma features, neither upon dermoscopy nor upon confocal microscopy examination. Seven lesions out of 201 cases (3.5%) were judged as negative on confocal examination, even if 6 of them were diagnosed as melanomas by clinical and/or dermoscopic evaluation. After histopathological revision, these cases were grouped into 5 categories: (1) amelanotic melanoma (n = 1), (2) hyperkeratotic melanomas (n = 2), (3) lentiginous melanomas (n = 2), (4) melanoma with small pagetoid cells (n = 1), (5) spitzoid melanoma (n = 1). Conclusion: Confocal and dermoscopic examination, along with patient-related information and clinical history, can lead to an optimal patient management.

Keywords:
Confocal microscopy, Dermoscopy, Melanoma, Skin cancer, Nevi, Histopathology
1.
UK CR melanoma statistics and outlook. http://cancerhelp.cancerresearchuk.org/type/melanoma/treatment/melanoma-statistics-and-outlook (accessed September 29, 2012).
2.
Scope A, Longo C: Recognizing the benefits and pitfalls of reflectance confocal microscopy in melanoma diagnosis. Dermatol Pract Concept 2014;4:67-71.
3.
Menzies SW, Zalaudek I: Why perform dermoscopy? The evidence for its role in the routine management of pigmented skin lesions. Arch Dermatol 2006;142:1211-1212.
4.
Aitken JF, Barbour A, Burmeister B, Taylor S, Walpole E; Australian Cancer Network; Smithers B; Melanoma Guidelines Revision Working Party: Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Sydney, Cancer Council Australia, Australian Cancer Network, Ministry of Health New Zealand, 2008.
5.
Dummer R, Hauschild A, Guggenheim M, Keilholz U, Pentheroudakis G: Cutaneous melanoma: ESMO clinical practice guidelines. Ann Oncol 2012;23(suppl 7):vii86-vii91.
6.
Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Spatz A, Grob JJ, Malvehy J, Newton-Bishop J, Stratigos A, Pehamberger H, Eggermont AM: Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - update 2012. European Dermatology Forum; European Association of Dermato-Oncology; European Organization of Research and Treatment of Cancer. Eur J Cancer 2012;48:2375-2390.
7.
Argenziano G, Cerroni L, Zalaudek I, Staibano S, Hofmann-Wellenhof R, Arpaia N, Bakos RM, Balme B, Bandic J, Bandelloni R, Brunasso AM, Cabo H, Calcara DA, Carlos-Ortega B, Carvalho AC, Casas G, Dong H, Ferrara G, Filotico R, Gómez G, Halpern A, Ilardi G, Ishiko A, Kandiloglu G, Kawasaki H, Kobayashi K, Koga H, Kovalyshyn I, Langford D, Liu X, Marghoob AA, Mascolo M, Massone C, et al: Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol 2012;67:54-59.
8.
Pellacani G, Pepe P, Casari A, Longo C: Reflectance confocal microscopy as a second-level examination in skin oncology improves diagnostic accuracy and saves unnecessary excisions: a longitudinal prospective study. Br J Dermatol 2014;171:1044-1051.
9.
Alarcon I, Carrera C, Palou J, Alos L, Malvehy J, Puig S: Impact of in vivo reflectance confocal microscopy on the number needed to treat melanoma in doubtful lesions. Br J Dermatol 2014;170:802-808.
10.
Pellacani G, Guitera P, Longo C, Avramidis M, Seidenari S, Menzies S: The impact of in vivo reflectance confocal microscopy for the diagnostic accuracy of melanoma and equivocal melanocytic lesions. J Invest Dermatol 2007;127:2759-2765.
11.
Longo C, Rito C, Beretti F, Cesinaro AM, Piñeiro-Maceira J, Seidenari S, Pellacani G: De novo melanoma and melanoma arising from pre-existing nevus: in vivo morphologic differences as evaluated by confocal microscopy. J Am Acad Dermatol 2011;65:604-614.
12.
Argenziano G, Catricalà C, Ardigo M, Buccini P, De Simone P, Eibenschutz L, Ferrari A, Mariani G, Silipo V, Sperduti I, Zalaudek I: Seven-point checklist of dermoscopy revisited. Br J Dermatol 2011;164:785-790.
13.
Pellacani G, Cesinaro AM, Seidenari S: Reflectance-mode confocal microscopy for the in vivo characterization of pagetoid melanocytosis in melanomas and nevi. J Invest Dermatol 2005;125:532-537.
14.
Guitera P, Menzies SW, Longo C, Cesinaro AM, Scolyer RA, Pellacani G: In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal cases. J Invest Dermatol 2012;132:2386-2394.
15.
Pellacani G, Farnetani F, Gonzales S, Longo C, Cesinaro AM, Beretti F, Seidenari S, Gilli M: In vivo confocal microscopy for detection and grading of dysplastic nevi: a pilot study. J Am Acad Dermatol 2012;66:e109-e121.
16.
Guitera P, Pellacani G, Crotty KA, Scolyer RA, Li LX, Bassoli S, Vinceti M, Rabinovitz H, Longo C, Menzies SW: The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face. J Invest Dermatol 2010;130:2080-2091.
17.
Maier T, Sattler EC, Braun-Falco M, Korting HC, Ruzicka T, Berking C: Reflectance confocal microscopy in the diagnosis of partially and completely amelanotic melanoma: report on seven cases. J Eur Acad Dermatol Venereol 2013;27:e42-e52.
18.
Braga JC, Scope A, Klaz I, Mecca P, González S, Rabinovitz H, Marghoob AA: The significance of reflectance confocal microscopy in the assessment of solitary pink skin lesions. J Am Acad Dermatol 2009;61:230-241.
19.
Busam KJ, Hester K, Charles C, Sachs DL, Antonescu CR, Gonzalez S, Halpern AC: Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy. Arch Dermatol 2001;137:923-929.
20.
Longo C, Moscarella E, Argenziano G, Lallas A, Raucci M, Pellacani G, Scope A: Reflectance confocal microscopy in the diagnosis of solitary pink skin tumors: review of diagnostic clues. Br J Dermatol 2015;173:31-41.
21.
Losi A, Longo C, Cesinaro AM, Benati E, Witkowski A, Guitera P, Pellacani G: Hyporeflective pagetoid cells: a new clue for amelanotic melanoma diagnosis by reflectance confocal microscopy. Br J Dermatol 2014;171:48-54.
22.
Longo C, Farnetani F, Ciardo S, Cesinaro AM, Moscarella E, Ponti G, Zalaudek I, Argenziano G, Pellacani G: Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study of 140 cases. Br J Dermatol 2013;169:58-67.
23.
King R: Lentiginous melanoma. Arch Pathol Lab Med 2011;135:337-341.
24.
King R, Page RN, Googe PB, Mihm MC Jr: Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus. Mod Pathol 2005;18:1397-1401.
25.
Zalaudek I, Cota C, Ferrara G, Moscarella E, Guitera P, Longo C, Piana S, Argenziano G: Flat pigmented macules on sun-damaged skin of the head/neck: junctional nevus, atypical lentiginous nevus, or melanoma in situ? Clin Dermatol 2014;32:88-93.
26.
Pellacani G, Longo C, Ferrara G, Cesinaro AM, Bassoli S, Guitera P, Menzies SW, Seidenari S: Spitz nevi: in vivo confocal microscopic features, dermatoscopic aspects, histopathologic correlates, and diagnostic significance. J Am Acad Dermatol 2009;60:236-247.
27.
Pellacani G, Cesinaro AM, Grana C, Seidenari S: In vivo confocal scanning laser microscopy of pigmented Spitz nevi: comparison of in vivo confocal images with dermoscopy and routine histopathology. J Am Acad Dermatol 2004;51:371-376.
28.
Ferrara G, Gianotti R, Cavicchini S, Salviato T, Zalaudek I, Argenziano G: Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview. Dermatol Clin 2013;31:589-598, viii.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.